Using CRC tissues from metastatic CRC patients that had survived previous conventional chemotherapy, Osada et al. [178] determined that T-cell-induced toxicity is mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody. The gene discussed is CEACAM5; the disease is colorectal carcinoma.